相关实验视频
Updated: Jun 14, 2025
07:43
Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
19.9K
用CD79A突变和耐火的Helicobacter Bilis感染扩大临床表型
Archan Sil1, Suprit Basu1, Kanika Arora1
1Allergy Immunology Unit, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Journal of clinical immunology
|August 31, 2024
概括
这项案例研究突出了8岁男孩罕见的自体逆向性聚糖球蛋白血症. 它详细介绍了使用向抗生素治疗耐火性Helicobacter bilis腿的成功,尽管持续时间长.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 传染性疾病 传染性疾病
背景情况:
- 自体递归性聚聚氨血症 (AR) 是一种严重的初级抗体缺乏症疾病.
- 它通常在婴儿期呈现,使得以后的呈现很少见.
研究的目的:
- 报告一个罕见的AR亚玛球蛋白血症病例,该病例发生在一个8岁的男孩身上,该男孩患有CD79A基因突变.
- 描述该患者耐火性Helicobacter bilis腿的治疗方法.
- 讨论原发性免疫缺陷的非典型发现和治疗策略.
主要方法:
- 在基因分析中,在CD79A基因中发现了一种同卵性拼接位变异 (c.499-1G>A).
- 患者接受了静脉注射免疫球蛋白替代剂和预防性抗生素.
- 用分子诊断来识别Helicobacter的物种.
- 治疗涉及长时间的静脉注射美罗,然后是口服的甲尼达和多西环素.
主要成果:
- 尽管接受了标准治疗,但患者患上了耐火的Helicobacter bilis腿.
- 通过向抗微生物治疗,在两年内实现了的解脱.
- 观察到持续的无症状血小板缺血,这是CD79A突变的非典型发现.
结论:
- 基因诊断对于管理原发性免疫缺陷的罕见感染至关重要.
- 针对性抗微生物治疗对于治疗耐火性感染,如Helicobacter bilis,至关重要.
- CD79A突变可能会出现不典型的临床表现,如血小板缺血.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
335
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
335
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
100
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
100